Elanco Animal Health (ELAN) Net Margin (2017 - 2026)

Elanco Animal Health has disclosed Net Margin across 10 years of filings, most recently posting 3.95% for Q2 2026.

• In Q2 2026, Net Margin rose 306.0% year-over-year to 3.95%; the TTM figure through Jun 2026 stood at 3.96% (down 1364.0% YoY), while the FY2025 annual figure was 4.92%, down 1253.0% from the prior year.
• Net Margin came in at 3.95% for Q2 2026 at Elanco Animal Health, down from 4.16% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 35.34% in Q3 2024 to a low of 102.62% in Q3 2023.
• Average Net Margin over 5 years is 5.85%, with a median of 0.82% recorded in 2022.
• Year-over-year, Net Margin tumbled 9629 bps in 2023 and soared 13796 bps in 2024.
• Over 5 years, Net Margin stood at 5.48% in 2022, then slumped by 148 bps to 13.62% in 2023, then surged by 94 bps to 0.78% in 2024, then tumbled by 2976 bps to 24.13% in 2025, then jumped by 116 bps to 3.95% in 2026.
• Per Business Quant data, the three most recent Net Margin figures were 3.95% in Q2 2026, 4.16% in Q1 2026, and 24.13% in Q4 2025.